Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Diseases and Conditions
  3. Malaria
Topic Menu

Malaria

  • Malaria Home
  • About Malaria
  • Statistics
  • For Health Professionals

Related Topics

  • Mosquitoborne Diseases
  • International Travel & Infectious Disease
  • Infectious Diseases A-Z
  • Reportable Infectious Diseases

 

Malaria

  • Malaria Home
  • About Malaria
  • Statistics
  • For Health Professionals

Related Topics

  • Mosquitoborne Diseases
  • International Travel & Infectious Disease
  • Infectious Diseases A-Z
  • Reportable Infectious Diseases

 

Contact Info
Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Contact Info

Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Malaria Information for Health Professionals

Artesunate for InjectionTM manufactured by Amivas(Amivas.com), is approved by the FDA, and is commercially available in the United States. FDA-approved artesunate is available for purchase from major drug distributors. For more details on acquiring IV artesunate, visit: CDC: Appendix C: How to Acquire IV Artesunate in the United States. Clinicians can call the CDC’s malaria hotline and receive consultations on diagnosis and management of malaria cases on a 24-hour basis, please call 770-488-7788 (from 9 a.m.-5 p.m. ET) or 770-488-7100 (after hours or on weekends and holidays). 

For more information on malaria from the CDC, please visit their website: Clinical Guidance: Malaria Diagnosis & Treatment in the U.S.

  • Reporting Malaria (Plasmodium spp.)
    Information from MDH on reporting malaria. Malaria (Plasmodium spp.) must be reported to MDH within one working day.
     
  • Minnesota Refugee Health Provider Guide, Chapter Eight: Malaria 
    Malaria at a Glance - Minnesota Initial Refugee Health Assessment.
     
  • FDA: Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria
    FDA guidance for industry to reduce the risk of transfusion-transmitted malaria.

MDH staff also are available to provide clinical consultation regarding testing and diagnosis of malaria and other mosquito-transmitted diseases. Call 651-201-5414 for a clinical consultation.

See also: Information for Health Care Professionals about Mosquitoborne Diseases
Resources, slides, reporting information and other clinical information for health professionals.

Tags
  • malaria
Last Updated: 03/27/2025

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube